The use of urethral bulking agents in the management of stress urinary incontinence TOG 2020 Flashcards
1
Q
How common is urinary incontinence UI in >20yea
A
25% (50% stress, 36% mixed, 11UUI)
2
Q
When arebulking agents offered
A
Primary treatments failed, declined or not fit for surgery
3
Q
What intramural bulking agents can be used
A
silicone, carbon-coated zirconium beads or hyaluronic acid/dextran copolymer
4
Q
What is in Bulkamid?
A
Polyacrylaminde hydrogel
5
Q
Success rates of Bulkamid at 1, 6 and 12 months
A
1 87%
6 71%
12 67%
6
Q
How often repeat injection needed
A
12-35%
7
Q
Complications of bulking agents
A
Complication rate 18%
Infection 5%
Pain 4%
Urinary retention 3.5%
8
Q
How many infections sites
A
3
9
Q
When should FU occur after bulking agent
A
3-6 months
